BG Medicine, Inc.
BG Medicine, Inc. (BGMD) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bgmd · pe ratio · data through Dec 31, 2015
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for BG Medicine, Inc. (BGMD) measures how much investors pay for each dollar of the company's trailing earnings. BGMD's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.55.
Source: FMP · /ratios-ttm · /analyst-estimates · 2015-12-31
PE Ratio History
2004 – 2015 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
BG Medicine, Inc.You BGMD | $0M | N/A | — | -$0.55 |
 American Medical Technologies Inc. ADLI | $0M | N/A | — | -$0.11 |
 Adynxx, Inc. ADYX | $0M | N/A | — | -$10.26 |
 BIMI International Medical Inc. BIMI | $0M | N/A | — | -$8.40 |
 Bionik Laboratories Corp. BNKL | $0M | N/A | — | -$0.72 |
 ContraFect Corporation CFRXQ | $0M | N/A | — | -$124.97 |
 DMK Pharmaceuticals Corporation DMKPQ | $0M | N/A | — | -$12.37 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2015-12-31Latest FY2015 | — | $-0.55 | — | |
2014-12-31 FY2014 | — | $-0.99 | — | |
2013-12-31 FY2013 | — | $-2.33 | — | |
2012-12-31 FY2012 | — | $-4.70 | — | |
2011-12-31 FY2011 | — | $-3.99 | — | |
2010-12-31 FY2010 | — | $-23.10 | — | |
2009-12-31 FY2009 | — | $-22.02 | — | |
2008-12-31 FY2008 | — | $-20.29 | — | |
2006-12-31 FY2006 | — | $-6.38 | — | |
2005-12-31 FY2005 | — | $-11.08 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for BG Medicine, Inc. (BGMD) measures how much investors pay for each dollar of the company's trailing earnings. BGMD's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.55.
Frequently asked questions
BGMD pe ratio · 6 questionsBGMD's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$0.55. Data sourced from Financial Modeling Prep via BGMD's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BG Medicine, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08